N
EVFM

Nuveen’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Nuveen’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,511
Closed -$459K – 3617
2021
Q1 		$459K Sell
17,511
-727
-4% -$33K ﹤0.01% 3115
2020
Q4 		$659K Buy
18,238
+162
+0.9% +$5.86K ﹤0.01% 2954
2020
Q3 		$640K Buy
18,076
+5,511
+44% +$240K ﹤0.01% 2861
2020
Q2 		$533K Buy
12,565
+10,090
+408% +$680K ﹤0.01% 2873
2020
Q1 		$198K Sell
2,475
-13
-0.5% -$1.04K ﹤0.01% 2999
2019
Q4 		$230K Hold
2,488
– – ﹤0.01% 3062
2019
Q3 		$188K Hold
2,488
– – ﹤0.01% 3128
2019
Q2 		$248K Buy
+2,488
New +$193K ﹤0.01% 3151

Other funds holding EVFM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Nuveen's EVFM Position: Q2 2021 in Review

Nuveen sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2021, closing a stake of 17,511 shares — an estimated $459K sold.

Nuveen first reported a position in EVFM in Q2 2019 and held it in 8 quarters. The position peaked at $659K in Q4 2020. 81 funds tracked by Wall St. Rank hold EVFM as of Q2 2021.

  • Nuveen reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 17,511 Evofem Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $459K.
  • Nuveen first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Nuveen's Evofem Biosciences, Inc. Common Stock position peaked at $659K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.